These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3216896)

  • 1. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
    Schömig E; Michael-Hepp J; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
    Bönisch H; Harder R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
    Kress HG; Schömig E
    Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transport of (+)-amphetamine by the neuronal noradrenaline carrier.
    Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):267-72. PubMed ID: 6514010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
    Foley KF; Cozzi NV
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).
    Schömig E; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):412-7. PubMed ID: 3029604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.
    Schömig E; Michael-Hepp J; Schönfeld CL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):495-501. PubMed ID: 2559331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.
    Schömig E; Körber M; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):626-32. PubMed ID: 2851105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of xylamine binding to proteins of PC12 pheochromocytoma cells.
    Koide M; Cho AK; Howard BD
    J Neurochem; 1986 Oct; 47(4):1277-85. PubMed ID: 3746302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cocaine and desipramine on neuronal uptake of [3H]-noradrenaline and sensitivity to noradrenaline of rat mesenteric resistance arteries.
    Byg AM; Bund S; Mulvany MJ; Aalkjaer C
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):623-30. PubMed ID: 7813121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter.
    Bönisch H; Martiny-Baron G; Blum B; Michael-Hepp J
    J Neural Transm Suppl; 1990; 32():413-9. PubMed ID: 2089105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site.
    Hara K; Yanagihara N; Minami K; Ueno S; Toyohira Y; Sata T; Kawamura M; Brüss M; Bönisch H; Shigematsu A; Izumi F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):328-33. PubMed ID: 9774220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):250-4. PubMed ID: 3587371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.
    Michael-Hepp J; Blum B; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):203-7. PubMed ID: 1333059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells).
    Harder R; Bönisch H
    J Neurochem; 1985 Oct; 45(4):1154-62. PubMed ID: 4031884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Oberleithner H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):65-70. PubMed ID: 2725700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.